TRIM Technology, TRIM Oligonucleotides to Antibody Library, the A-Z
Luke McLaughlin
Scientific Digital Marketing, Synthetic Biology, Nucleic Acid Therapeutics and Antibody Engineering, Biotech Writer | Manager of Marketing And Business Development, Stay Curious, Stay Innovative
Designing TRIM Oligonucleotide Libraries: The Foundation of Precision Antibody Engineering
The generation of diverse and highly specific antibody libraries using phage display technology is a cornerstone of modern antibody engineering and drug discovery. At the heart of this process is the creation of TRIM (TriNucleotide Mixture) oligonucleotide libraries, which enable precise control over amino acid diversity and codon representation. These libraries are engineered to explore vast sequence spaces, offering flexibility to include all amino acids equally or bias the selection toward residues of known functional importance, such as aromatic residues that enhance antigen interaction. Conversely, residues like cysteine, which can form unintended disulfide bonds, are often excluded unless necessary for structural stability. Designing these libraries requires sophisticated computational tools to optimize codon usage for the expression system, ensuring compatibility with host tRNA availability and translation machinery.
?The creation of TRIM (TriNucleotide Mixture) oligonucleotide libraries is an intricate process designed to maximize sequence diversity while maintaining control over amino acid composition and codon usage. These libraries are central to antibody discovery using phage display technology, as they allow researchers to encode a virtually limitless range of protein sequences. Let’s delve deeper into the technical aspects of TRIM library generation, focusing on amino acid diversity, codon representation, and the optimization process.
TRIM libraries are engineered to ensure a wide sequence space is explored, allowing researchers to probe for antibodies with unique and specific binding properties. Each position in a TRIM library is encoded using mixtures of codons that correspond to a defined subset of amino acids.
To equally represent all 20 amino acids, researchers use a uniform mixture of trinucleotide codons. For example, the degenerate codon NNK (N = A/T/C/G, K = G/T) encodes all 20 amino acids while minimizing the introduction of stop codons.
Balanced libraries ensure that every possible sequence combination has an equal probability of being represented.
In cases where specific amino acids are favored due to functional or structural reasons, codon mixtures are adjusted to enrich those residues. For example, residues like tyrosine, tryptophan, and phenylalanine are often overrepresented in antibody libraries because of their ability to participate in πstacking and hydrophobic interactions with antigens.
Residues like cysteine are typically excluded because they can form unplanned disulfide bonds, leading to misfolded proteins. However, in cases where disulfide bonds are integral to the protein's stability or function, controlled inclusion of cysteine codons may be implemented.
The genetic code is redundant, meaning multiple codons encode the same amino acid. This redundancy must be carefully managed during TRIM library design to ensure that codon usage aligns with the host organism’s translational efficiency.
TRIM libraries utilize predefined mixtures of trinucleotides to encode amino acids. For instance
NNK Encodes 32 codons (20 amino acids + 1 stop codon).
NNS Uses G or C for the third position, slightly altering representation and potentially favoring host expression.
These codons are chosen to balance diversity while reducing the risk of introducing premature stop codons.
Host organisms like E. coli have biased tRNA pools, meaning some codons are translated more efficiently than others. Optimizing codon usage to match this bias is critical for highefficiency protein expression.
Tools like Codon Usage Optimizer or proprietary algorithms analyze hostspecific tRNA availability and adjust codon ratios accordingly.
The design of TRIM libraries often begins with computational modeling to predict library diversity and validate codon choices. Key tools and strategies include
Algorithms predict the theoretical diversity of the library, ensuring that the number of unique sequences is sufficient for the intended application. For example, a library designed to cover all 20 amino acids across 10 variable positions can theoretically encode 201020^{10}2010 combinations, but practical constraints like synthesis errors may reduce this number.
Researchers may impose constraints to limit or promote specific structural features. For example
Restricting glycine at positions critical for rigidity.
Promoting proline at loop positions to enhance conformational stability.
Sequences prone to forming unintended secondary structures, such as hairpins, are identified and excluded to maintain library functionality.
Several technical challenges arise during the design and synthesis of TRIM libraries, requiring careful mitigation strategies.
DNA synthesis methods, particularly when using degenerate codons, are prone to errors like base mismatches or truncations. Highfidelity synthesis and rigorous purification (e.g., HPLC or PAGE) are employed to address this.
Amplification of oligonucleotides can introduce bias, skewing the representation of certain sequences. Optimized PCR protocols with highfidelity polymerases minimize these effects.
The practical size of TRIM libraries is limited by transformation efficiency and the host's ability to accommodate highdiversity plasmid pools. Strategies such as electroporation into highefficiency competent cells help maximize transformation rates.
After designing a TRIM library, validation is essential to confirm that the theoretical diversity is realized in practice.
NGS technologies allow researchers to sequence large portions of the library, providing a comprehensive view of its diversity. Discrepancies between the designed and actual library guide adjustments in future iterations.
Preliminary binding assays test the library’s ability to produce functional antibodies, confirming that the diversity encompasses relevant sequence motifs.
TRIM library design is a highly technical and iterative process that combines computational design, precise chemical synthesis, and rigorous validation. By carefully managing amino acid diversity, codon representation, and host compatibility, researchers create libraries capable of exploring immense sequence spaces, ultimately driving the discovery of nextgeneration therapeutic antibodies.
?
High-Fidelity Synthesis and Purification: Ensuring Quality in Antibody Library Construction
Once the library is designed, it undergoes highfidelity chemical synthesis, typically using solidphase methods. This step involves carefully controlled cycles of nucleotide addition to generate the precise sequences required. Postsynthesis, purification using highperformance liquid chromatography (HPLC) or polyacrylamide gel electrophoresis (PAGE) removes truncated or erroneous sequences, ensuring only fulllength oligonucleotides progress to the next steps. Amplification of the purified library via PCR further increases the material available for downstream processing. Highfidelity DNA polymerases like Phusion or Q5 minimize amplification bias and reduce the risk of introducing mutations. In cases where synthesis errors are a concern, enzymatic error correction methods, such as MutS mismatch repair, are employed to enhance library accuracy and quality.
?
Solidphase chemical synthesis is the preferred method for creating TRIM libraries due to its precision and scalability. The process involves iterative cycles of nucleotide addition, with each step chemically controlled to ensure accuracy.
The synthesis begins with a solid support, typically a resin bead or controlled pore glass (CPG), functionalized with a reactive group that anchors the first nucleotide.
Each synthesis cycle involves the sequential addition of protected nucleotides
Phosphoramidites These are chemically protected nucleotides, used to ensure only the 3’hydroxyl group participates in bond formation.
Activation Tetrazole or a similar acid catalyst activates the phosphoramidite, allowing it to react with the growing chain.
The cycle proceeds as follows
Deprotection A mild acidic wash removes the 5’dimethoxytrityl (DMT) group, exposing the next reactive hydroxyl group.
Coupling The activated phosphoramidite reacts with the exposed 3’hydroxyl group of the growing chain.
Capping Unreacted chains are capped with acetic anhydride to prevent errors in the next cycle.
Oxidation The phosphite triester bond is oxidized to a stable phosphate diester using iodine.
This process is repeated for each nucleotide, building the sequence one base at a time. For TRIM libraries, mixtures of nucleotides are added at degenerate positions to encode the desired diversity.
Once synthesis is complete, the oligonucleotide is cleaved from the solid support, and protective groups are removed under alkaline or reducing conditions.
Despite the precision of solidphase synthesis, errors can occur, such as incomplete coupling, premature chain termination, or side reactions. These errors are mitigated by
Coupling Efficiencies Optimizing reaction times and reagent concentrations to maintain >99% coupling efficiency at each step.
Purification PostSynthesis Employing highresolution methods like HPLC to remove incomplete or truncated sequences.
?
To ensure the integrity of the synthesized oligonucleotide library, purification is performed to separate fulllength products from truncated or erroneous sequences. Two main techniques are used
HPLC separates molecules based on size, charge, or hydrophobicity. For oligonucleotides, reversephase HPLC or ionexchange HPLC is commonly used.
The oligonucleotide mixture is passed through a column containing a stationary phase (e.g., silica beads).
A mobile phase gradient (e.g., acetonitrile and water) elutes the oligonucleotides, with fulllength sequences having distinct retention times.
Provides high resolution and reproducibility.
Removes synthesis byproducts and truncated products effectively.
PAGE separates oligonucleotides by size, as smaller fragments migrate faster through the gel matrix.
The crude product is loaded onto a denaturing polyacrylamide gel, which disrupts secondary structures and ensures sizebased separation.
Fulllength bands are visualized (e.g., UV shadowing) and excised for recovery.
Allows precise separation and visualization of fulllength products.
Once purified, the library is amplified to increase the quantity of oligonucleotides for downstream applications. Amplification must preserve library diversity and avoid introducing biases or errors.
Phusion DNA Polymerase and Q5 HighFidelity Polymerase are commonly used due to their
Low Error Rates Error rates are typically 10?610^{6}10?6 to 10?710^{7}10?7 per nucleotide, ensuring minimal sequence distortion.
Processivity These enzymes can synthesize long stretches of DNA efficiently, critical for longer oligonucleotides.
Primer Design
Primers must anneal specifically to the flanking regions of the library without introducing additional biases.
Denaturation, annealing, and extension steps are finely tuned to avoid amplification bias
Lower annealing temperatures reduce sequence dropout.
Extension times are optimized based on the length of the oligonucleotides.
Minimizing the number of cycles (e.g., 20–25) reduces the risk of overamplification, which can skew the representation of certain sequences.
Equalization Techniques Adjusting reagent concentrations (e.g., dNTPs, MgCl2) ensures even amplification across all sequences.
Reaction Splitting Dividing the library into smaller reactions reduces competition among sequences during amplification.
?
Errors introduced during synthesis or amplification can reduce library quality. To address this, enzymatic error correction methods, such as MutS mismatch repair, are applied.
Mechanism
MutS protein identifies mismatches or small insertion/deletion errors in doublestranded DNA.
MutL and MutH enzymes recruit endonucleases to excise the errorcontaining strand.
Application
The purified library is denatured and reannealed to create heteroduplex DNA, which contains mismatched regions from synthesis errors.
MutS targets these mismatches, and the corrected library is amplified for downstream use.
Advantages of Error Correction
Increases the accuracy and functionality of the library.
Reduces downstream sequencing and screening burdens by removing erroneous sequences early.
?
Following synthesis, purification, and amplification, the library undergoes rigorous validation to ensure it meets design specifications.
HighThroughput Sequencing (HTS)
Purpose
Confirms that the diversity of the library matches the theoretical design.
Process
Libraries are sequenced using platforms like Illumina or PacBio to analyze thousands of sequences simultaneously.
Data Analysis
Computational tools assess codon representation, amino acid diversity, and error rates.
By following this precise workflow, researchers create highquality TRIM libraries that retain the designed sequence diversity, laying a strong foundation for antibody discovery and engineering. This combination of highfidelity synthesis, robust purification, and stringent validation ensures that only the most accurate and diverse libraries are used for downstream applications.
Vector Assembly and Validation: Integrating TRIM Libraries into Phagemid Systems
Following amplification, the oligonucleotides are ligated into phagemid vectors, which act as vehicles for expressing antibody fragments. Preparing these vectors involves digestion with restriction enzymes to generate compatible ends and dephosphorylation to prevent selfligation. The TRIM library is then ligated into the vector backbone using T4 DNA ligase, a process optimized by controlling the vectortoinsert ratio and employing ligationenhancing buffers. After ligation, the resulting constructs are validated using colony PCR to confirm the presence of inserts. Highthroughput sequencing (HTS) is often employed to verify library diversity and ensure that the desired amino acid distributions are achieved.
Phagemid vectors are plasmidbased DNA molecules engineered for phage display applications. They serve as carriers for the antibody fragments encoded by the TRIM library, enabling their subsequent display on the surface of bacteriophages. Preparing these vectors for ligation involves multiple steps to ensure compatibility with the TRIM inserts and to prevent undesired outcomes such as vector selfligation.
Vectors are digested with restriction enzymes that create specific, compatible ends (sticky or blunt). These enzymes target unique sites within the multiple cloning site (MCS) of the vector.
Common restriction enzymes include EcoRI, NotI, or XbaI, depending on the sequence design of the TRIM library and vector backbone.
A combination of two restriction enzymes is often used to create noncomplementary sticky ends, ensuring directional insertion of the TRIM library. Directionality is critical for maintaining the correct reading frame for downstream expression of antibody fragments.
To prevent the vector’s cut ends from religating to themselves during the ligation step, which would drastically reduce the efficiency of library construction.
Alkaline phosphatases such as calf intestinal phosphatase (CIP) or shrimp alkaline phosphatase (SAP) are used to remove the 5'phosphate groups from the vector ends.
The phosphatase reaction is performed under conditions that preserve the integrity of the vector while ensuring complete dephosphorylation. After dephosphorylation, the enzyme is heatinactivated or removed via purification.
The digested and dephosphorylated vector is purified to remove enzymes, small DNA fragments, and other contaminants. Techniques include
Gel extraction The linearized vector is separated on an agarose gel and excised for purification.
Columnbased purification Spin columns efficiently remove unwanted reaction components.
?
The next step is the ligation of the TRIM oligonucleotide library into the prepared phagemid vector. This process requires precise control over several factors to maximize efficiency and preserve library diversity.
T4 DNA ligase catalyzes the formation of phosphodiester bonds between the 3'hydroxyl and 5'phosphate groups of DNA fragments.
The reaction requires ATP as a cofactor and works optimally at specific temperature and buffer conditions.
Optimization
The molar ratio of vector to insert must be carefully calculated to maximize ligation efficiency while preventing the formation of undesired byproducts (e.g., vector dimers or multiple inserts).
Typical ratios range from 13 to 110 (vectorinsert) depending on the size of the library insert and the complexity of the vector.
Insert Concentration
The concentration of the TRIM library must be precisely measured using spectrophotometric methods (e.g., NanoDrop) or fluorometric assays (e.g., Qubit) to ensure accurate stoichiometry.
Ligation Buffers
Specialized buffers containing polyethylene glycol (PEG) enhance ligation efficiency by crowding DNA molecules together, increasing the likelihood of end joining.
Temperature Cycling
A temperature gradient ligation strategy alternates between 16°C (optimal for ligase activity) and 25°C (to improve DNA end pairing). This approach enhances both efficiency and yield.
?
Following ligation, the phagemid constructs are introduced into E. coli cells for amplification. This step is critical for increasing the quantity of the recombinant plasmid and is also the first stage where library diversity begins to be realized.
Competent E. coli strains such as TG1 or XL1Blue are commonly used for phage display applications.
High transformation efficiencies (e.g., >10810^8108 CFU/μg DNA) are required to ensure sufficient representation of the entire library.
Electroporation
Highvoltage pulses create temporary pores in the bacterial membrane, allowing DNA uptake.
Electroporation is preferred for large libraries because of its high efficiency.
Chemical Transformation
Heat shock at 42°C is used to facilitate DNA uptake in chemically competent cells, though this method is less efficient than electroporation.
?
Once the ligation and transformation steps are complete, the constructs are validated to confirm successful insertion of the TRIM library and assess library diversity.
Individual bacterial colonies are picked, and PCR is used to amplify the inserted region of the phagemid vector.
Primers flanking the MCS amplify the inserted library fragments, and successful ligation is indicated by the presence of a PCR product of the expected size.
PCR products are analyzed on an agarose gel to confirm the presence and size of the insert.
Restriction Analysis
Plasmids extracted from transformed colonies can be digested with restriction enzymes to verify the presence of inserts.
Properly inserted library fragments produce bands of expected sizes when analyzed by agarose gel electrophoresis.
Purpose
HTS provides a comprehensive analysis of the library, confirming that the diversity of the designed TRIM library is maintained and that the amino acid distributions align with the design specifications.
Platforms
Platforms like Illumina or Oxford Nanopore are commonly used for sequencing library constructs.
Analysis
Bioinformatics tools assess the representation of codons and amino acids, ensuring that no biases or unintended errors have been introduced during synthesis, ligation, or amplification.
?
It is essential to ensure that the diversity of the original TRIM library is preserved throughout ligation and validation
Avoiding Bottlenecks
Transformation efficiency must be high enough to represent the full theoretical diversity of the library (e.g., >109>10^9>109 clones for a library with 10910^9109 unique sequences).
Minimizing Bias
Reaction conditions for ligation and amplification are carefully controlled to avoid favoring certain sequences over others.
By adhering to these optimized protocols and validating at each stage, the resulting constructs provide a robust foundation for the next steps in phage display, ensuring that the diversity and integrity of the antibody library are retained. This meticulous approach is critical for the successful identification of highaffinity antibody candidates in subsequent biopanning and screening processes.
?
Transformation and Phage Assembly: Preparing TRIM Libraries for Display
The next step is transforming the ligated phagemid library into E. coli cells, a critical process for amplifying the library and preparing it for phage display. This can be done via chemical transformation, where competent cells treated with calcium chloride undergo a brief heat shock to facilitate DNA uptake, or through electroporation, which uses a highvoltage pulse to transiently permeabilize the bacterial membrane. Highefficiency strains such as TG1 or XL1Blue are typically used to maximize transformation efficiency. After transformation, the bacterial cells are infected with a helper phage like M13KO7, which supplies the necessary proteins for phage assembly and secretion.
Transformation introduces the ligated phagemid DNA into E. coli cells. Two widely used methods for this purpose are chemical transformation and electroporation. Both approaches have distinct mechanisms, advantages, and considerations.
Chemical transformation is a straightforward method that leverages chemical treatments to make the bacterial membrane permeable to DNA.
E. coli cells are treated with divalent cations such as calcium chloride (CaCl?) or rubidium chloride (RbCl?) in an icecold solution. These cations neutralize the negative charges on the bacterial membrane and the DNA, facilitating DNA binding to the cell surface.
The ligated phagemid library is mixed with competent cells and incubated on ice. The low temperature stabilizes the interaction between the DNA and the bacterial membrane.
A heat shock step at 42°C for 30–60 seconds briefly disrupts the membrane structure, allowing the DNA to pass into the cytoplasm.
The cells are then quickly cooled on ice to restore membrane integrity.
Recovery
After heat shock, cells are incubated in a nutrientrich recovery medium (e.g., SOC or LB broth) at 37°C for 30–60 minutes. This step allows the cells to express antibiotic resistance genes from the phagemid and recover from the transformation process.
Advantages
Simplicity and costeffectiveness.
Sufficient for libraries with moderate diversity (10610^6106–10710^7107 transformants).
Limitations
Lower transformation efficiency compared to electroporation, which can be a bottleneck for highly diverse libraries.
Electroporation
Electroporation uses a highvoltage electric pulse to transiently permeabilize the bacterial membrane, enabling DNA uptake. This method is preferred for highdiversity libraries due to its superior efficiency.
Preparation of Electrocompetent Cells
E. coli cells are washed multiple times in icecold sterile water or 10% glycerol to remove ionic contaminants that could cause arcing during electroporation.
The cells are resuspended in a small volume of icecold glycerol and stored at ?80°C for longterm use.
Electroporation Protocol
The ligated phagemid library is mixed with electrocompetent cells in a chilled electroporation cuvette with a narrow electrode gap (e.g., 1 mm).
A highvoltage pulse (typically 2.5 kV, 25 μF, 200 Ω) is applied, creating a transient electric field that forms pores in the membrane and facilitates DNA uptake.
The cells are immediately diluted in recovery medium to stabilize the membrane and allow plasmid expression.
Advantages
High transformation efficiency (>108>10^8>108–10910^9109 transformants/μg DNA).
Essential for large libraries requiring representation of billions of unique clones.
Limitations
Requires specialized equipment and careful preparation of cells to avoid cell death due to arcing.
?
Host Strain Selection
The choice of E. coli strain is critical for achieving high transformation efficiencies and maintaining library diversity. Commonly used strains for phagemidbased antibody libraries include
Features
High transformation efficiency.
F? phenotype, which enables infection by filamentous phages like M13.
Tolerates large plasmids, making it ideal for phagemid vectors.
Applications
Widely used for constructing and amplifying antibody libraries.
Features
Highefficiency transformation capability.
RecA? and endA? mutations that improve plasmid stability by reducing recombination and nuclease activity.
Compatible with helper phage infection for phage particle production.
SS320 An engineered strain optimized for phage display applications.
ER2738 Commonly used for M13 phage propagation due to its robust growth characteristics.
?
Infection with Helper Phages
Once the phagemid library is transformed into E. coli, the next step is infection with a helper phage like M13KO7. Helper phages provide the necessary proteins for phage assembly and secretion, enabling the display of antibody fragments on the phage surface.
Role of Helper Phages
Phagemids are incapable of producing all the proteins required for phage assembly. Helper phages supply these missing elements, including structural proteins like pVIII (major coat protein) and pIII (minor coat protein, used for antibody display).
Infection Protocol
Infection Step
The transformed E. coli cells are grown to midlog phase (OD600 ~0.5–0.7) in a selective medium containing antibiotics (e.g., ampicillin for phagemids and kanamycin for helper phages).
Cells are then infected with the helper phage at a multiplicity of infection (MOI) of 10–20 to ensure efficient uptake of the phage.
Incubation is carried out for 30–60 minutes at 37°C without shaking to allow phage adsorption.
Superinfection
After initial infection, cultures are diluted in fresh medium containing both antibiotics to select for cells carrying both the phagemid and the helper phage.
Helper Phage Variants
M13KO7
The most widely used helper phage. It carries a kanamycin resistance gene and is optimized for highyield phage production.
Hyperphage
Engineered to increase the display density of antibody fragments on the phage surface, useful for applications requiring multivalent binding.
?
领英推荐
Validation of Transformation Efficiency
The success of the transformation and infection processes is validated to ensure that the library's diversity and integrity are maintained.
Transformation efficiency (CFU/μgCFU/\mu gCFU/μg) is calculated by plating serial dilutions of transformed cells onto selective agar plates and counting the resulting colonies.
For a library with theoretical diversity of 10910^9109, transformation must achieve at least 10910^9109 independent colonies to avoid loss of unique sequences.
Colony PCR can be used to confirm the presence of the phagemid.
Highthroughput sequencing verifies the diversity of the library after transformation and infection.
?This carefully controlled process ensures that the ligated phagemid library is successfully introduced into E. coli cells and that the cells are equipped to produce phage particles displaying antibody fragments. Maintaining high transformation efficiencies and ensuring compatibility with helper phages are critical to preserving library diversity and enabling effective downstream screening in phage display experiments.
?
Phage Display Assembly: Linking Genotype to Phenotype for Antibody Selection
Inside the E. coli cells, phage particles are assembled with the antibody fragments fused to a coat protein, such as pIII or pVIII. This fusion creates a direct link between the genotype (the phagemid DNA) and the phenotype (the displayed antibody fragment), enabling downstream selection processes. The phage particles are secreted into the culture supernatant and purified via polyethylene glycol (PEG) precipitation. This method involves adding PEG and a highsalt buffer to precipitate the phages, followed by centrifugation and resuspension in a storage buffer for subsequent biopanning.
The assembly of phage particles in E. coli cells begins with the expression of components encoded by the phagemid and helper phage. The process culminates in the formation of filamentous bacteriophage particles that display antibody fragments fused to coat proteins.
pIII (Minor Coat Protein)
pIII is located at the tip of the filamentous phage and is typically used for the display of larger proteins like antibody fragments (e.g., scFvs or Fabs).
Antibody fragments are fused to the Nterminus of pIII, ensuring their exposure on the phage surface.
pVIII (Major Coat Protein)
pVIII forms the bulk of the phage's filamentous structure and can display smaller peptides due to its abundance (up to 2700 copies per phage).
Its use in antibody display is less common due to the size and structural constraints of antibody fragments.
The phagemid DNA contains
The antibody fragment gene fused to the coat protein gene (typically pIII or pVIII).
An origin of replication for propagation in E. coli.
Antibiotic resistance markers for selection.
When expressed in E. coli, the antibody fragment is translated and cotranslationally inserted into the phage coat as part of the assembling particle. This creates a direct link between the displayed protein (phenotype) and its corresponding DNA sequence (genotype) within the phage.
The helper phage (e.g., M13KO7) provides all additional phage proteins necessary for particle assembly and secretion.
The phagemid competes with the helper phage genome during packaging, ensuring that most phage particles carry the phagemid DNA.
Helper phage genomes are engineered with mutations or replication disadvantages to ensure preferential packaging of phagemid DNA.
?
Unlike lytic phages, filamentous phages like M13 do not lyse their host cells. Instead, the phage particles are secreted through the bacterial membrane into the culture medium.
Secretion Mechanism
Phage assembly occurs at the inner membrane of E. coli.
The singlestranded phagemid DNA is replicated into a doublestranded intermediate, which is used as a template to produce singlestranded DNA.
Newly synthesized singlestranded DNA is coated with capsid proteins, forming a mature phage particle.
The particle is secreted via a phageencoded secretion apparatus that spans the bacterial membrane, releasing the phage into the extracellular environment.
Host cells remain viable and continue producing phage particles over time, enabling scalable production.
?
Once secreted, phage particles are recovered from the culture supernatant for use in biopanning and other downstream applications. The most common method for phage purification is polyethylene glycol (PEG) precipitation.
PEG precipitation is a simple and effective method to concentrate phage particles by exploiting their solubility properties in highsalt solutions.
Principle
PEG is a hydrophilic polymer that reduces the solubility of phage particles in aqueous solutions. When combined with salt (e.g., NaCl), PEG facilitates the aggregation and precipitation of phage particles.
Procedure
Culture Supernatant Collection
After centrifugation to pellet E. coli cells, the culture supernatant containing secreted phage particles is collected.
PEG Solution Addition
PEG8000 (10% w/v final concentration) and NaCl (2.5 M final concentration) are added to the supernatant. The solution is mixed thoroughly and incubated on ice for 30–60 minutes to allow phage precipitation.
Centrifugation
The mixture is centrifuged at high speed (10,000–15,000 × g) for 20–30 minutes at 4°C. This step pellets the phage particles.
Resuspension
The pellet is carefully resuspended in a small volume of storage buffer, such as phosphatebuffered saline (PBS) or Trisbuffered saline (TBS), to maintain phage stability.
Considerations
PEG precipitation is scalable, making it suitable for processing large culture volumes.
Residual PEG or salt can interfere with downstream applications and should be removed if necessary (e.g., by dialysis or ultrafiltration).
Alternative Purification Methods
CsCl Gradient Ultracentrifugation
A highpurity method for phage isolation, but laborintensive and less commonly used for routine applications.
Immunoaffinity Purification
Useful for isolating phage particles displaying specific antibody fragments, leveraging antigencoated beads or columns.
?
Validation of Purified Phage
Purified phage preparations must be validated to confirm their integrity and suitability for downstream applications such as biopanning.
Titering Phage Particles
The phage concentration (titer) is determined by infecting E. coli cells with serial dilutions of the purified phage and plating them on selective agar plates. Plaqueforming units (PFUs) are counted to quantify the titer.
Functional Validation
Phage preparations are tested in binding assays to confirm the display of functional antibody fragments on the phage surface.
Quality Control
Agarose gel electrophoresis is used to verify the integrity of the phage DNA.
Electron microscopy can be employed to confirm the morphology of the phage particles.
?
Storage of Purified Phage
Phage particles are stable when stored under appropriate conditions
Buffer Phages are typically resuspended in PBS or TBS with 1% BSA or another stabilizing agent.
Temperature Longterm storage is at ?80°C in 15–50% glycerol, while shortterm storage is at 4°C.
Avoid FreezingThawing Multiple freezethaw cycles should be avoided to prevent phage degradation.
?
This comprehensive process ensures the production and purification of highquality phage particles, each displaying antibody fragments on their surface. These particles are ready for use in biopanning and subsequent selection of highaffinity antibodies, maintaining the critical genotypephenotype linkage essential for phage display technology.
?
Biopanning: Refining Antibody Libraries for High-Affinity Target Binding
Biopanning is the critical step where phage particles displaying antibody fragments are screened for their ability to bind a specific target antigen. Antigens are immobilized on surfaces such as microplates, beads, or magnetic particles, creating a matrix for selective binding. The phage library is incubated with the immobilized antigen, allowing specific binders to interact. To reduce nonspecific interactions, stringent wash conditions are applied, using buffers containing detergents like Tween20 or highsalt concentrations. Bound phages are then eluted, often using lowpH glycine buffers or competitive elution with excess soluble antigen. The eluted phages, enriched for highaffinity binders, are amplified in E. coli and subjected to additional rounds of panning—typically three to five cycles—to further refine the selection.
?
Antigen Immobilization
The first step in biopanning is immobilizing the target antigen to create a solidphase matrix for binding interactions with phagedisplayed antibody fragments.
Surfaces for Immobilization
Microplates (e.g., ELISA Plates)
Antigens are adsorbed onto the wells of polystyrene plates. Hydrophobic interactions between the antigen and plate surface facilitate binding.
Plates can be coated directly or pretreated with capture molecules (e.g., streptavidin for biotinylated antigens or Protein A/G for antibodies).
Magnetic Beads
Beads are functionalized with specific groups (e.g., carboxyl, amine) or coated with capture molecules to allow covalent or noncovalent antigen attachment.
Magnetic separation allows rapid and efficient washing, particularly for complex libraries or stringent conditions.
Agarose Beads
Used for largescale panning or when gentle conditions are required to maintain antigen conformation.
Covalent vs. NonCovalent Immobilization
Antigens are covalently attached to reactive surfaces via chemical linkers like EDC/NHS for carboxyl groups or maleimide for thiols.
Provides stable attachment but may affect antigen activity if reactive residues are within binding epitopes.
NonCovalent Immobilization
Antigens adsorb passively to surfaces or bind to preattached capture molecules like streptavidin.
Easier to perform and preserves antigen activity, but may be less stable under stringent washing conditions.
?
The phage library is incubated with the immobilized antigen to allow specific binders to interact.
Library Preparation
Phage particles are diluted in a binding buffer (e.g., PBS, TBS) supplemented with blocking agents like bovine serum albumin (BSA) or skim milk to prevent nonspecific interactions.
Typical phage input is 1011?101310^{11} ?10^{13}1011?1013 phage particles per round, depending on the library diversity and antigen abundance.
Time and Temperature
Binding is typically carried out for 1–2 hours at room temperature or 4°C to maintain the antigen's structural integrity and promote highaffinity interactions.
Buffer Composition
Salt concentrations (e.g., 150–300 mM NaCl) and pH (usually 7.4) are optimized to mimic physiological conditions or enhance binding specificity.
?
Stringent washing is critical to eliminate nonspecific binders and ensure that only highaffinity phages remain bound to the antigen.
Buffer Composition
Wash buffers typically include
Detergents Tween20 or Triton X100 disrupt nonspecific hydrophobic interactions.
High Salt NaCl or KCl at concentrations up to 1 M reduces electrostatic interactions.
pH Variations Mildly acidic or basic buffers may improve stringency by destabilizing weak interactions.
Washing Stringency
Stringency is gradually increased over successive rounds of panning
First Round Moderate wash conditions to retain weak binders.
Later Rounds Higher detergent concentrations, more washes, and longer durations to select for highaffinity binders.
Wash Methodologies
Static Plates Buffer is aspirated and replaced multiple times.
Beads Magnetic or agarose beads are washed by resuspension and magnetic separation or centrifugation.
?
Bound phages are eluted from the immobilized antigen for subsequent amplification and repanning. Elution conditions are chosen to disrupt the antigenantibody interaction while preserving phage integrity.
Low pH Elution
A glycineHCl buffer (pH 2.2–2.5) disrupts electrostatic and hydrogenbonding interactions.
Eluted phages are immediately neutralized with Tris buffer to prevent damage to the phage particles.
Competitive Elution
Excess soluble antigen (free form of the immobilized antigen) competes for binding, releasing phages specifically bound to the antigen.
Ideal for preserving phage integrity and maintaining high specificity.
High Salt or Urea
High ionic strength (e.g., 3 M NaCl) or denaturants like urea disrupt weaker interactions.
Used for more robust phageantigen pairs.
Considerations for Elution
The elution method must balance efficiency (recovering as many bound phages as possible) with stringency (avoiding coelution of nonspecific binders).
?
Amplification of Eluted Phages
The eluted phages are amplified in E. coli to increase their quantity and prepare them for subsequent rounds of panning.
Host Cells
Highefficiency E. coli strains like TG1 or XL1Blue are used for amplification.
Cells are grown in selective media (e.g., LB broth with ampicillin) to ensure that only phagemidcarrying cells survive.
Infection and Phage Production
Eluted phages are used to infect the host cells, initiating phagemid replication and phage particle assembly.
Helper phages (e.g., M13KO7) are added to enable the secretion of new phage particles.
?
Iterative Rounds of Panning
Biopanning is repeated for multiple rounds (typically 3–5) to enrich for highaffinity binders.
Enrichment Across Rounds
Each round increases the stringency of binding and washing conditions, progressively favoring phages with higher affinity and specificity for the target antigen.
Enrichment is monitored by measuring the phage recovery rate (output/input ratio) at each round.
Library Evolution
Lowaffinity or nonspecific binders are diluted out with each round, leaving a population dominated by highaffinity clones.
?
Validation of Selected Phages
After the final round of panning, the enriched phage pool is analyzed to identify unique antibody candidates.
Individual Clone Screening
Single colonies are isolated, and the phagemid DNA is sequenced to identify unique clones.
Binding assays (e.g., ELISA) are performed to confirm target specificity and affinity.
NextGeneration Sequencing (NGS)
NGS of the phage pool provides a comprehensive overview of the enriched library, identifying dominant clones and sequence diversity.
?
Biopanning is a finely tuned, iterative process that leverages antigenphage interactions to isolate highaffinity antibody candidates. Each step, from antigen immobilization to elution and amplification, is optimized to balance specificity, sensitivity, and library diversity. By the end of multiple rounds, biopanning yields a focused pool of phages enriched for antibody fragments with the desired binding properties, paving the way for further characterization and therapeutic development.
?
Validation and Functional Testing: Characterizing and Evaluating Antibody Candidates
After biopanning, the enriched antibody candidates are subjected to rigorous validation and functional testing. DNA sequencing is used to identify unique clones and assess library diversity after panning. Selected clones are expressed in appropriate host systems, such as mammalian cells for fulllength antibodies or yeast for antibody fragments like scFvs or Fabs. Purification of these proteins follows, often through affinity chromatography using Protein A/G for antibodies or antigenspecific columns for direct capture. Functional assays, such as enzymelinked immunosorbent assays (ELISA), surface plasmon resonance (SPR), or biolayer interferometry (BLI), measure binding affinity and specificity. For therapeutic applications, additional assays like neutralization tests or cellbased activity measurements are performed to evaluate biological function.
DNA Sequencing and Library Diversity Analysis
DNA Extraction from Enriched Clones
Individual phage clones are isolated by infecting E. coli, plating on selective agar plates, and picking colonies.
Plasmid DNA is extracted using miniprep kits or rapid alkaline lysis methods.
For pooled phages, DNA can be extracted directly from the phage particles by denaturation with SDSProteinase K and ethanol precipitation.
Sequencing Techniques
Sanger Sequencing
Singlecolony DNA is amplified using primers specific to the phagemid vector, and the insert is sequenced to identify unique antibody candidates.
Costeffective for smallscale screening of individual clones.
NextGeneration Sequencing (NGS)
Provides a comprehensive analysis of the enriched library, identifying dominant clones and sequence diversity.
Tools like Illumina or Oxford Nanopore platforms analyze thousands of clones simultaneously, ensuring that rare but highaffinity binders are not overlooked.
Analysis of Sequencing Data
Sequence Clustering
Bioinformatics tools (e.g., BLAST, Clustal Omega) cluster sequences into families based on complementaritydetermining region (CDR) similarities.
Clusters are prioritized based on their prevalence and diversity.
Mutational Analysis
Unique mutations in the antibody variable regions are examined for their potential impact on binding specificity and affinity.
?
Expression in Host Systems
Once promising clones are identified, they are expressed in appropriate systems to produce sufficient quantities of functional antibodies for further testing.
Choice of Host Systems
Mammalian Cells (e.g., HEK293, CHO)
Preferred for expressing fulllength IgG antibodies.
Ensure proper posttranslational modifications (e.g., glycosylation) and folding, critical for therapeutic applications.
Yeast (e.g., Pichia pastoris)
Used for expressing antibody fragments like scFvs or Fabs.
Rapid growth and costeffective for initial screening, though posttranslational modifications may differ from those in humans.
Bacterial Systems (e.g., E. coli)
Suitable for smaller fragments (e.g., scFvs or singledomain antibodies).
Simple and inexpensive, but lacks posttranslational modifications.
Expression Workflow
Subcloning
Antibody genes are subcloned into expression vectors containing strong promoters (e.g., CMV for mammalian systems) and appropriate tags (e.g., Histag or Fctag) for purification.
Transient Transfection
For rapid antibody production, mammalian cells are transiently transfected using reagents like polyethyleneimine (PEI) or commercial kits.
Stable Cell Line Generation
For largescale production, stable cell lines are created by integrating the antibody gene into the host genome and selecting transfected cells using antibiotics or fluorescence markers.
Culture Optimization
Media and growth conditions are optimized for maximum yield and functionality.
?
Protein Purification
The expressed antibodies or fragments are purified from the culture supernatant or lysate for functional testing. High purity is essential for reliable assay results.
Affinity Chromatography
Protein A/G Columns
Used for fulllength IgG antibodies.
Protein A binds the Fc region of antibodies with high specificity, allowing efficient capture and elution.
Elution typically uses a lowpH buffer (e.g., glycineHCl, pH 2.5–3.0), with immediate neutralization to prevent degradation.
AntigenSpecific Columns
Antibodies are purified by binding to immobilized target antigens, ensuring specificity.
Useful for isolating functional antibodies directly from crude mixtures.
Additional Purification Steps
SizeExclusion Chromatography (SEC)
Removes aggregates and ensures monodispersity, which is critical for biophysical assays.
IonExchange Chromatography
Separates antibodies based on charge, useful for removing closely related impurities.
Purity Assessment
SDSPAGE or capillary electrophoresis evaluates purity and molecular weight.
Analytical SEC confirms the absence of aggregates.
?
Functional Assays
Binding Assays
ELISA (EnzymeLinked Immunosorbent Assay)
Plates are coated with the target antigen, and serial dilutions of the antibody are applied to measure binding activity.
Detection relies on enzymelabeled secondary antibodies and chromogenic substrates.
Provides a semiquantitative measure of binding strength.
Surface Plasmon Resonance (SPR)
Realtime binding kinetics (association and dissociation rates) are measured by immobilizing the antigen on a sensor chip and flowing the antibody over it.
SPR calculates equilibrium dissociation constant (KDK_DKD), a critical measure of binding affinity.
Biolayer Interferometry (BLI)
Similar to SPR but uses fiberoptic tips instead of a sensor chip.
Useful for highthroughput screening of binding interactions.
Specificity Testing
Binding to offtarget antigens is assessed using ELISA or SPR to confirm that the antibody binds selectively to the intended target.
?
Biological and Functional Assays
For therapeutic applications, the biological activity of the antibody must be validated in functional assays.
Neutralization Assays
Virus Neutralization
Antibodies are tested for their ability to inhibit viral infection in cell culture systems.
Efficacy is measured by the reduction in viral titers or reporter gene activity.
Toxin Neutralization
Antibodies are incubated with toxins, and their ability to block toxicity is assessed in cell viability assays.
CellBased Activity Assays
ADCC (AntibodyDependent Cellular Cytotoxicity)
Measures the antibody's ability to recruit immune effector cells to kill target cells.
Uses effector cells (e.g., NK cells) and target cells expressing the antigen, with readouts like lactate dehydrogenase (LDH) release or luminescence.
CDC (ComplementDependent Cytotoxicity)
Assesses whether the antibody can activate the complement cascade to lyse target cells.
Epitope Mapping
Identifies the specific region of the antigen bound by the antibody using techniques like alanine scanning mutagenesis or hydrogendeuterium exchange mass spectrometry (HDXMS).
?
Stability and Developability Testing
To determine the therapeutic potential, antibodies are subjected to stress tests and developability assessments.
Thermal Stability
Differential scanning calorimetry (DSC) or temperaturegradient SEC measures the antibody’s thermal denaturation midpoint (TmT_mTm).
Aggregation Propensity
Dynamic light scattering (DLS) assesses the propensity for aggregation under stress conditions (e.g., heat, shaking, or freezethaw cycles).
Immunogenicity Prediction
Computational tools analyze the sequence for potential immunogenic epitopes that could elicit adverse immune responses in humans.
?
By combining rigorous sequencing, expression, purification, and functional testing, this workflow ensures that only the highestquality antibody candidates progress to further development. Each stage provides critical insights into the antibody's binding properties, specificity, and potential therapeutic efficacy, setting the stage for preclinical and clinical studies.
Bullet Point Summary Conclusion
CEO-Azemidite Biopharm
3 个月Thanks for the professional sharing
Scientist at Ayushi Biotech
3 个月Very informative